Literature DB >> 3895609

Doyne lecture. Heterochromic iridocyclitis.

G R O'Connor.   

Abstract

Fuchs' heterochromic iridocyclitis is a rare but significant cause of visual impairment. This form of uveitis is misdiagnosed more than any other in the entire field of uveitis. This is particularly true among brown-eyed individuals in whom gross heterochromia may not be diagnosed for many years. The clinical presentation of Fuchs' heterochromic iridocyclitis may include a number of generally unrecognised variants among which are Koeppe nodules, transient synechia formations, and blood-filled cysts. Recently the relationship of heterochromic iridocyclitis to posterior inflammatory lesions, such as those of toxoplasmosis, has been explored. Although the disease was once thought to be a degenerative or trophic disorder, current investigations reveal that it is a true inflammation of immunologic origin. The disorder may be related to a depression of suppressor T-cell activity. The aetiology of the disease is still obscure, but in some cases an association with simple heterochromia has been found among families in whom multiple members are affected by either simple heterochromia or Fuchs' heterochromic iridocyclitis. Corticosteroid treatment of Fuchs' heterochromic iridocyclitis is not effective and should be reserved for those patients in whom inflammatory products obstruct the visual axis. Most patients should be treated by observation alone. Cataract and glaucoma are the most important complications. Treatment of the glaucoma is particularly difficult and often unsuccessful.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3895609

Source DB:  PubMed          Journal:  Trans Ophthalmol Soc U K        ISSN: 0078-5334


  10 in total

1.  Cataract surgery in Fuchs' heterochromic iridocyclitis.

Authors:  D R Sherwood; A R Rosenthal
Journal:  Br J Ophthalmol       Date:  1992-04       Impact factor: 4.638

2.  Fuchs' cyclitis: a statistical chronology of its signs.

Authors:  E Vadot
Journal:  Int Ophthalmol       Date:  1990-10       Impact factor: 2.031

3.  Surgical management of cataract and posterior chamber intraocular lens implantation in Fuchs' heterochromic iridocyclitis.

Authors:  M Soheilian; F Karimian; M A Javadi; H Sajjadi; H Ahmadieh; M Azarmina; N Valaee; B Rahmani; G A Peyman
Journal:  Int Ophthalmol       Date:  1997       Impact factor: 2.031

4.  Analysis of iris structure and iridocorneal angle parameters with anterior segment optical coherence tomography in Fuchs' uveitis syndrome.

Authors:  Berna Basarir; Cigdem Altan; Eylem Yaman Pinarci; Ugur Celik; Banu Satana; Ahmet Demirok
Journal:  Int Ophthalmol       Date:  2013-01-01       Impact factor: 2.031

5.  High incidence of corneal epithelium antibodies in Fuch's heterochromic cyclitis.

Authors:  E la Hey; G S Baarsma; A Rothova; L Broersma; R van der Gaag; A Kijlstra
Journal:  Br J Ophthalmol       Date:  1988-12       Impact factor: 4.638

Review 6.  Fuchs' heterochromic cyclitis: review of the literature on the pathogenetic mechanisms.

Authors:  E La Hey; P T de Jong; A Kijlstra
Journal:  Br J Ophthalmol       Date:  1994-04       Impact factor: 4.638

7.  Glaucoma in Fuchs' heterochromic cyclitis associated with congenital Horner's syndrome.

Authors:  L S Regenbogen; N Naveh-Floman
Journal:  Br J Ophthalmol       Date:  1987-11       Impact factor: 4.638

8.  Clinical analysis of Fuchs' heterochromic cyclitis.

Authors:  E La Hey; G S Baarsma; J De Vries; A Kijlstra
Journal:  Doc Ophthalmol       Date:  1991       Impact factor: 2.379

9.  Does autoimmunity to S-antigen play a role in Fuchs' heterochromic cyclitis?

Authors:  E La Hey; L Broersma; R van der Gaag; G S Baarsma; A Rothova; A Kijlstra
Journal:  Br J Ophthalmol       Date:  1993-07       Impact factor: 4.638

10.  Surgical management of secondary glaucoma in Fuchs' heterochromic iridocyclitis.

Authors:  Yi-An You; Yaming Wu; Saijing Hu
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-03-22       Impact factor: 3.117

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.